Skip to main content
. 2015 Mar 30;5:9384. doi: 10.1038/srep09384

Figure 1. Antitumor activity of PHY906, one herb deleted PHY906, and/or Sorafenib on HepG2 tumor growth in NCR nude mice.

Figure 1

(A) Effect of PHY906 and/or Sorafenib on HepG2 (human) tumor growth in NCR nude mice. Error bars indicate standard deviations and N = 14. (B) Effect of one herb deleted of PHY906 and Sorafenib on HepG2 tumor growth in NCR nude mice. Error bars indicate standard deviations and N = 5. Sorafenib (30 mg/kg, b.i.d., daily) and PHY906 (500 mg/kg, b.i.d.) was administered orally from day 0 to day 3. Details of experimental procedures are given in Materials and Methods. T-test was used to compare the difference of Sorafenib vs. PHY906 or one herb deleted of PHY906 at day 7. P values are indicated in the graphs.